Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

32.20
Delayed Data
As of 4:01pm ET
 +2.22 / +7.40%
Today’s Change
26.81
Today|||52-Week Range
74.77
-51.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.1B

Company Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Contact Information

Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard
Pasadena California 91105
P:(626) 304-3400
Investor Relations:

Employees

Shareholders

Mutual fund holders41.58%
Individual stakeholders4.09%
Other institutional25.44%

Top Executives

Christopher Richard AnzalonePresident, Chief Executive Officer & Director
Patrick C. O'brienCOO, Secretary & Chief Compliance Officer
Kenneth Allen MyszkowskiChief Financial Officer
Javier San MartinChief Medical Officer
Peter CarignanVice President-Clinical Operations